IMPLANTABLE MEDICAL DEVICE FOR THE DELIVERY OF BISPHOSPHONATE
An implantable medical device is provided. The core includes a core polymer matrix within which is dispersed a therapeutic agent comprising one or more bisphosphonates. The core polymer matrix contains an ethylene vinyl acetate copolymer. The ethylene vinyl acetate copolymer has a vinyl acetate cont...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
09.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | An implantable medical device is provided. The core includes a core polymer matrix within which is dispersed a therapeutic agent comprising one or more bisphosphonates. The core polymer matrix contains an ethylene vinyl acetate copolymer. The ethylene vinyl acetate copolymer has a vinyl acetate content of from about 10 wt.% to about 60 wt.% and/or a melting temperature of from about 40°C to about 120°C as determined in accordance with ASTM D3418-15.
L'invention concerne un dispositif médical implantable. Le noyau comprend une matrice polymère centrale à l'intérieur de laquelle est dispersé un agent thérapeutique comprenant un ou plusieurs bisphosphonates. La matrice polymère centrale contient un copolymère éthylène-acétate de vinyle. Le copolymère éthylène-acétate de vinyle a une teneur en acétate de vinyle d'environ 10 % en poids à environ 60 % en poids et/ou une température de fusion d'environ 40 °C à environ 120 °C telle que déterminée conformément à la norme ASTM D3418-15. |
---|---|
Bibliography: | Application Number: WO2022US38795 |